感染症内科　ただいま診断中！

出版社： 中外医学社
著者：
発行日： 2017-10-30
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784498021266
電子書籍版： 2017-10-30 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

7,480 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

7,480 円(税込)

購入する

商品紹介

本書は感染症内科を研修する初期・後期研修医を対象に，“臨床感染症の実践的な知識”を短期で習得することを目的に作成された．肺炎や尿路感染症といったような，お馴染みな疾患挙げて解説するのではなく，診断に至るための基本的アプローチ，臨床推論の基本や問診の在り方，バイタルサインの診かたや身体診察など，どうすれば“正しい診断”にたどり着くことができるか，そのロジックとプロセス丁寧に解説しているところが最大の特徴．

目次

  • 1　感染症診療の基本的アプローチ
    　　感染症診療のロジック

    2　感染症診療における臨床推論と問診
    　　問診の理論と実践

    3　感染症診療におけるバイタルサインと身体診察

    4　感染症診療におけるグラム染色

    5　血液培養で診断を詰める
    　　日々是血培

    6　胸水貯留患者の診断アプローチ
    　　胸水穿刺はBecause it’s there

    7　腹水貯留患者の診断アプローチ

    8　髄膜炎患者の診断アプローチ　
    　　慌てず，焦らず，急ぐ

    9　関節炎患者の診断アプローチ
    　　化膿性関節炎を見逃さない

    10　感染症診療におけるバイオマーカーの運用
    　　CRPと周辺のバイオマーカーについて

    11　術後患者の発熱の診断アプローチ
    　　発症時期と病因を主軸に考える

    12　他科との連携が必要な皮膚軟部組織感染症
    　　壊死性軟部組織感染症を見逃がさない

    13　感染症内科医が併診すべき菌血症
    　　黄色ブドウ球菌菌血症とカンジダ血症

    14　下痢症患者の診断アプローチ
    　　たかが下痢，されど下痢

    ミニレクチャー
    　アンチバイオグラムの作り方
    　敗血症と敗血症性ショックの新しい定義と診断基準
    　陽性血液培養ボトルのパターンから原因菌を推定する
    　打診と聴性打診

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 感染症診療の基本的アプローチ 感染症診療のロジック

P.26 掲載の参考文献
2) Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163(5):545-51.
 
3) Kushimoto S, Gando S, Saitoh D, et al;JAAM Sepsis Registry Study Group. The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis:an analysis from a multicenter, prospective survey of severe sepsis. Crit Care. 2013;17(6):R271.
 
4) 倉井華子, 他. がん患者の感染症診療マニュアル改訂2版. 南山堂;2012.
 
5) Safdar A. Principles and Practice of Cancer Infectious Diseases. Humana Press;2011.
 
6) Sinwar PD. Overwhelming post splenectomy infection syndrome - review study. Int J Surg. 2014;12(12):1314-6.
 
7) Mathew H, Dittus C, Malek A, et al. Howell-Jolly bodies on peripheral smear leading to the diagnosis of congenital hyposplenism in a patient with septic shock. Clin Case Rep. 2015;3(8):714-7.
 
8) Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487-98.
 
9) Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11(6):954-63.
 
10) Dixon WG, Abrahamowicz M, Beauchamp ME, et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis:a nested case-control analysis. Ann Rheum Dis. 2012;71(7):1128-33.
 
11) Ichinose Y, Hara N, Motohiro A, et al. Influence of chemotherapy on superoxide anion-generating activity of polymorphonuclear leukocytes in patients with lung cancer. Cancer. 1986;58(8):1663-7.
 
12) Bodey GP. Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents. 2000;16(2):93-5.
 
13) Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 1975;135(5):715-9.
 
14) Valdivieso M, Gil-extremera B, Zornoza J, et al. Gram-negative bacillary pneumonia in the compromised host. Medicine (Baltimore). 1977;56(3):241-54.
 
15) Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30 Suppl 1:S51-9.
 
16) Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med. 2002;30(12):2632-5.
 
17) Yoneyama T, Yoshida M, Mukaiyama H, et al. Oral care reduces pneumonia of elderly patients in nursing homes. J Am Geriatr Soc. 2002;50(3):430-3.
 
18) Labeau SO, Van de Vyver K, Brusselaers N, et al. Prevention of ventilatorassociated pneumonia with oral antiseptics:a systematic review and meta-analysis. Lancet Infect Dis. 2011;11(11):845-54.
 
19) Norisue Y, Tokuda Y, Koizumi M, et al. Phasic characteristics of inspiratory crackles of bacterial and atypical pneumonia. Postgrad Med J. 2008;84(994):432-6.
 
20) Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-50.
 
21) Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study. Thorax. 2003;58(5):377-82.
 
22) 日本呼吸器学会感染症に関するガイドライン作成委員会, 編. 成人市中肺炎診療ガイドライン. 2007.
 
23) Yamamoto S, Yamazaki S, Shimizu T, et al. Prognostic utility of serum CRP levels in combination with CURB-65 in patients with clinically suspectedsepsis:a decision curve analysis. BMJ Open. 2015;5(4):e007049.
 
24) Gupta K, Hooton TM, Naber KG, et al;Infectious Diseases Society of America;European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women:A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-20.
 
25) Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32-40.
 
26) Bruns AH, Oosterheert JJ, Prokop M, et al. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis. 2007;45(8):983-91.
 
27) Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia:implications for practice guidelines. JAMA. 1998;279(18):1452-7.
 
28) Rubin LG, Levin MJ, Ljungman P, et al;Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309-18.
 
29) Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions:recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816-9.
 
30) Briere EC, Rubin L, Moro PL, et al;Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC. Prevention and control of haemophilus influenzae type b disease:recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63(RR-01):1-14.
 
31) Cohn AC, MacNeil JR, Clark TA, et al;Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease:recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-2):1-28.
 
32) Bodey GP, Buckley M, Sathe YS, et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328-40.
 
33) Freifeld AG, Bow EJ, Sepkowitz KA, et al;Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer:2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427-31.
 
34) 日本臨床腫瘍学会. 発熱性好中球減少症(FN)診療ガイドライン. 南江堂;2012.
 
35) Nesher L, Rolston KV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 2014;42(1):5-13.
 
36) Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013;56(5):711-7.
 
37) Chopra V, Govindan S, Kuhn L, et al. Do clinicians know which of their patients have central venous catheters?:a multicenter observational study. Ann Intern Med. 2014;161(8):562-7.
 
38) Silva BN, Andriolo RB, Atallah AN, et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2013;(3):CD007934.
 
39) Ohji G, Doi A, Yamamoto S, et al. Is de-escalation of antimicrobials effective? A systematic review and meta-analysis. Int J Infect Dis. 2016;49:71-9.
 
P.36 掲載の参考文献
1) Moehring RW, Hazen KC, Hawkins MR, et al. Challenges in preparation of cumulative antibiogram reports for community hospitals. J Clin Microbiol. 2015;53(9):2977-82.
 
2) Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test. Data;Approved Guideline-Fourth Edition. CLSI;2014.
 

2 感染症診療における臨床推論と問診 問診の理論と実践

P.60 掲載の参考文献
1) Ajjawi R. Learning to communicate clinical reasoning in physiotherapy practice. 2007. https://ses.library.usyd.edu.au/handle/2123/1556 [Accessed 2016-07]
 
2) Peterson MC, Holbrook JH, Von Hales D, et al. Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. West J Med. 1992;156(2):163-5.
 
3) Hampton JR, Harrison MJ, Mitchell JR, et al. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J. 1975;2(5969):486-9.
 
4) Evans JS. Dual-processing accounts of reasoning, judgment, and social cognition. Annu Rev Psychol. 2008;59:255-78.
 
5) Bate L, Hutchinson A, Underhill J, et al. How clinical decisions are made. Br J Clin Pharmacol. 2012;74(4):614-20.
 
6) Croskerry P. The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med. 2003;78(8):775-80.
 
7) Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-84.
 
8) CDC. A Guide to Taking a Sexual History. Available from:https://www.cdc.gov/std/treatment/sexualhistory.pdf [Accessed 2016-07]
 
9) McGee S. Chapter 2, Diagnostic Accuracy of Physical Findings. Evidence-Based Physical Diagnosis, 3rd ed. Saunders;2012. p.9-21.
 
10) Sackett DL. The rational clinical examination. A primer on the precision and accuracy of the clinical examination. JAMA. 1992;267(19):2638-44.
 
11) Jensen GM. Clinical reasoning:linking theory to practice and practice to theory. J Neurol Phys Ther. 1994;23:137-44.
 
12) Reynolds C, Quan V, Kim D, et al. Methicillin-resistant Staphylococcus aureus (MRSA) carriage in 10 nursing homes in Orange County, California. Infect Control Hosp Epidemiol. 2011;32:91-3.
 
13) Blom A, Ahl J, Mansson F, et al. The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home:a cross-sectional comparison. BMC Infect Dis. 2016;16:111.
 
14) Castellani LR, Gold WL, MacFadden DR. A 25-year-old woman reporting an allergy to penicillin. CMAJ. 2015;187(14):1065-6.
 
15) Salkind AR, Cuddy PG, Foxworth JW. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA. 2001;285(19):2498-505.
 
16) Campagna JD, Bond MC, Schabelman E, et al. The use of cephalosporins in penicillin-allergic patients:a literature review. J Emerg Med. 2012;42(5):612-20.
 
17) Kula B, Djordjevic G, Robinson JL. A systematic review:can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins? Clin Infect Dis. 2014;59(8):1113-22.
 
18) Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase:implications for antibiotic use. Antimicrob Agents Chemother. 2008;52(3):995-1000.
 
19) Patel RA, Gallagher JC. Drug fever. Pharmacotherapy. 2010;30(1):57-69.
 
20) Cohen SH, Gerding DN, Johnson S, et al;Society for Healthcare Epidemiology of America;Infectious Diseases Society of America. Infect Control Hosp Epidemiol. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.
 
21) Tanaka T, Hirata T, Parrott G, et al. Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer:A 24-Year Cohort Inpatient Study in Okinawa, Japan. Am J Trop Med Hyg. 2016;94(2):365-70.
 
22) Sasaki Y, Taniguchi T, Kinjo M, et al. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1:a single-center experience in Japan between 1990 and 2010. Infection. 2013;41(6):1189-93.
 
23) 忽那賢志. 症例から学ぶ輸入感染症 A to Z. 中外医学社;2015.
 
24) Leder K, Torresi J, Libman MD, et al;GeoSentinel Surveillance Network. Geo-Sentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013;158(6):456-68.
 
25) Spira AM. Assessment of travellers who return home ill. Lancet. 2003;361(9367):1459-69.
 
26) 谷崎勝朗. レジオネラ症に対する温泉浴の注意点とは? Geriatric Medicine(老年医学). 2006;44(4):565-6.
 
27) 坂本龍太, 他. レジオネラ症の隠れた感染経路, 自動車の運転や雨天は危険因子か? IASR. 2008, 29:331-2.
 

3 感染症診療におけるバイタルサインと身体診察

P.98 掲載の参考文献
1) Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369(18):1726-34.
 
2) Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006;34(3):589-97.
 
3) Allgower M, Burri C. "Shock index". Dtsch Med Wochenschr. 1967;92(43):1947-50.
 
4) Berger T, Green J, Horeczko T, et al. Shock index and early recognition of sepsis in the emergency department:pilot study. West J Emerg Med. 2013;14(2):168-74.
 
5) Kristensen AK, Holler JG, Hallas J, et al. Is shock index a valid predictor of mortality in emergency department patients with hypertension, diabetes, high age, or receipt of β- or calcium channel blockers? Ann Emerg Med. 2016;67(1):106-13. e6.
 
6) Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
 
7) Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis:For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762-74.
 
8) Iacobone E, Bailly-Salin J, Polito A. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med. 2009;37(10 Suppl):S331-6.
 
9) McGee S. Evidence-Based Physical Diagnosis, 3rd ed. Saunders;2012.
 
10) Deakin CD, Low JL. Accuracy of the advanced trauma life support guidelines for predicting systolic blood pressure using carotid, femoral, and radial pulses:observational study. BMJ. 2000;321(7262):673-4.
 
11) Mason JW, Ramseth DJ, Chanter DO, et al. Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. J Electrocardiol. 2007;40(3):228-34.
 
12) Mawatari K, Sanada J, Kuroiwa N, et al. Mechanism of production of pulse deficit in atrial fibrillation:assessment by blood flow dynamics. J Cardiol. 1988;18(1):197-205.
 
13) Yusuf S, Camm AJ. The sinus tachycardias. Nat Clin Pract Cardiovasc Med. 2005;2(1):44-52.
 
14) Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clin Microbiol Infect. 2000;6(12):633-4.
 
15) Willis GC. 松村理司, 訳. Dr. ウィリスのベッドサイド診断-病歴と身体診察でここまでわかる! 医学書院;2008.
 
16) Niven DJ, Gaudet JE, Laupland KB, et al. Accuracy of peripheral thermometers for estimating temperature:a systematic review and meta-analysis. Ann Intern Med. 2015;163(10):768-77.
 
17) Simon HB. Extreme pyrexia. JAMA. 1976;236(21):2419-21.
 
18) Pittet D, Thievent B, Wenzel RP. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med. 1996;153(2):684-93.
 
19) Hamano J, Tokuda Y. Changes in vital signs as predictors of bacterial infection in home care:a multi-center prospective cohort study. Postgrad Med. 2017;129(2):283-7.
 
20) Vazquez R, Gheorghe C, Kaufman D, et al. Accuracy of bedside physical examination in distinguishing categories of shock:a pilot study. J Hosp Med. 2010;5(8):471-4.
 
21) Cook DJ, Simel DL. The Rational Clinical Examination. Does this patient have abnormal central venous pressure? JAMA. 1996;275(8):630-4.
 
22) Steven L. Berk and Abraham Verghese. Chapter 217. General Appearance. In:Walker HK, et al, editors. Clinical Methods:The History, Physical, and Laboratory Examinations. 3rd ed. Butterworths;1990.
 
23) Fawcett RS, Linford S, Stulberg DL. Nail abnormalities:clues to systemic disease. Am Fam Physician. 2004;69(6):1417-24.
 
24) Lovibond JL. The diagnosis of clubbed fingers. Lancet. 1938;1:363-4.
 
25) Myers KA, Farquhar DR. The rational clinical examination. Does this patient have clubbing? JAMA. 2001;286(3):341-7.
 
26) Schamroth L. Personal experience. S Afr Med J. 1976;50(9):297-300.
 
27) Desmond P, Raman R, Idikula J. Effect of nasogastric tubes on the nose and maxillary sinus. Crit Care Med. 1991;19(4):509-11.
 
28) Abba AA, Khalil MZ. Clinical approach to lymphadenopathy. Ann Nigerian Med. 2012;6:11-7.
 
29) Ferrer R. Lymphadenopathy:differential diagnosis and evaluation. Am Fam Physician. 1998;58(6):1313-20.
 
30) Pangalis GA, Vassilakopoulos TP, Boussiotis VA, et al. Clinical approach to lymphadenopathy. Semin Oncol. 1993;20(6):570-82.
 
31) Fijten GH, Blijham GH. Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract. 1988;27(4):373-6.
 
32) Paauw DS, Wenrich MD, Curtis JR, et al. Ability of primary care physicians to recognize physical findings associated with HIV infection. JAMA. 1995;274(17):1380-2.
 
33) Siminoski K. The rational clinical examination. Does this patient have a goiter? JAMA. 1995;273(10):813-7.
 
34) 金城紀与史, 前野哲博, 岸本暢将, 監訳. 身体診察シークレット. メディカル・サイエンス・インターナショナル;2009.
 
35) Nath AR, Capel LH. Lung crackles in bronchiectasis. Thorax. 1980;35(9):694-9.
 
36) Nath AR, Capel LH. Inspiratory crackles-early and late. Thorax. 1974;29(2):223-7.
 
37) Norisue Y, Tokuda Y, Koizumi M, et al. Phasic characteristics of inspiratory crackles of bacterial and atypical pneumonia. Postgrad Med J. 2008;84(994):432-6.
 
38) Piirila P. Changes in crackle characteristics during the clinical course of pneumonia. Chest. 1992;102(1):176-83.
 
39) Iversen K, Nielsen OW, Kirk V, et al. Heart murmur and N-terminal pro-brain natriuretic peptide as predictors of death in 2977 consecutive hospitalized patients. Am J Med Sci. 2008;335(6):444-50.
 
40) Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases:a population-based study. Lancet. 2006;368(9540):1005-11.
 
41) Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368(15):1425-33.
 
42) Aubin C. Evidence-based emergency medicine/rational clinical examination abstract. Does this woman have an acute uncomplicated urinary tract infection? Ann Emerg Med. 2007;49(1):106-8.
 
43) Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010;362(11):1022-9.
 
44) Priest DH, Peacock JE Jr. Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult:clinical features and therapeutic outcomes. South Med J. 2005;98(9):854-62.
 
45) Bickley LS. Bates' Guide to Physical Examination and History Taking, 10th ed. Lippincott Williams & Wilkins;2008.
 
46) Staniland JR, Ditchburn J, De Dombal FT. Clinical presentation of acute abdomen:study of 600 patients. Br Med J. 1972;3(5823):393-8.
 
47) Naylor CD. The rational clinical examination. Physical examination of the liver. JAMA. 1994;271(23):1859-65.
 
48) Ueda T, Ishida E. Indirect fist percussion of the liver is a more sensitive technique for detecting hepatobiliary infections than murphy's sign. Curr Gerontol Geriatr Res. 2015;2015:431638.
 
49) Henry JA, Altmann P. Assessment of hypoproteinaemic oedema:a simple physical sign. Br Med J. 1978;1(6117):890-1.
 
50) Gill BC, Shoskes DA. Bacterial prostatitis. Curr Opin Infect Dis. 2016;29(1):86-91.
 
51) Smithson A, Ramos J, Netto C, et al. Acute prostatitis in men with urinary tract infection and fever:diagnostic yield of rectal examination findings in the emergency department. Emergencias. 2012;24:292-5.
 

4 感染症診療におけるグラム染色

P.127 掲載の参考文献
1) Coico R. Gram staining. Curr Protoc Immunol. 2001;Appendix 3:Appendix 3O.
 
2) Fukuyama H, Yamashiro S, Kinjo K. Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia:a prospective observational study. BMC Infect Dis. 2014;14:534.
 
3) Taniguchi T, Tsuha S, Shiiki S, et al. Gram-stain-based antimicrobial selection reduces cost and overuse compared with Japanese guidelines. BMC Infect Dis. 2015;15:458.
 
4) Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004;38(8):1150-8.
 
5) 中澤武司. 塗抹検査. 臨床と微生物. 2010;37(4):301-7.
 
6) Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25-9.
 
7) European Association of Urology 2015. Available at:http://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf Accessed 11 January 2017.
 
8) Hooton TM, Bradley SF, Cardenas DD, et al;Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults:2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-3.
 
9) Ramanathan R, Duane TM. Urinary tract infections in surgical patients. Surg Clin North Am. 2014;94(6):1351-68.
 
10) Shah PS, Cannon JP, Sullivan CL, et al. Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in spinal-cord-injury patients with chronic indwelling catheters. Am J Health Syst Pharm. 2005;62(1):74-7.
 
11) Miller DL. A study of techniques for the examination of sputum in a field survey of chronic bronchitis. Am Rev Respir Dis. 1963;88:473-83.
 
12) Geckler RW, Gremillion DH, McAllister CK, et al. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol. 1977;6(4):396-9.
 
13) Jenkins RD, Fenn JP, Matsen JM. Review of urine microscopy for bacteriuria. JAMA. 1986;255(24):3397-403.
 
14) Chan WW. Stainning Procedure, 3.2.1. Gram Stain. Clinical Microbiology Procedures Handbook, 4th ed. AMS Press;2016.
 
15) Church D, Melnyk E, Unger B. Quantitative gram stain interpretation criteria used by microbiology laboratories in Alberta, Canada. J Clin Microbiol. 2000;38(11):4266-8.
 
16) Ogihara S, Saito R, Akikura T, et al. Characterization of mucoid and non-mucoid Streptococcus pneumoniae isolated from outpatients. Ann Lab Med. 2015;35(4):410-5.
 
17) Rein MF, Gwaltney JM Jr, O'Brien WM, et al. Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA. 1978;239(25):2671-3.
 
18) Yamamoto G. Can you detect organisms and diagnose bacterial infections from microscopic examinations? Rinsho Byori. 2013;61(8):729-34.
 
19) Murdoch DR, Greenlees RL. Rapid identification of Staphylococcus aureus from BacT/ALERT blood culture bottles by direct Gram stain characteristics. J Clin Pathol. 2004;57(2):199-201.
 
20) Uehara Y, Yagoshi M, Tanimichi Y, et al. Impact of reporting gram stain results from blood culture bottles on the selection of antimicrobial agents. Am J Clin Pathol. 2009;132(1):18-25.
 
21) Song Z, Wu H, Ciofu O, et al. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection. J Med Microbiol. 2003;52(Pt 9):731-40.
 
22) Tanaka T, Goto M, Okuzumi K, et al. Isolation and identification of Helicobacter cinaedi and H. cinaedi-like organisms isolated from blood culture in practical laboratory procedures. Kansenshogaku Zasshi. 2007;81(6):700-6.
 
23) Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2004;39(2):165-9.
 

5 血液培養で診断を詰める 日々是血培

P.147 掲載の参考文献
1) Ruiz-Giardin JM, Jimenez BC, Martin RM, et al. Clinical diagnostic accuracy of suspected sources of bacteremia and its effect on mortality. Eur J Intern Med. 2013;24(6):541-5.
 
2) 田中希世, 堀谷亮介, 伊東直哉, 他. 頭痛と髄膜刺激徴候を欠いたリステリア髄膜炎の1例. 市立堺病院医学雑誌. 2013;15:21-4.
 
3) Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults:Diagnosis, antimicrobial therapy, and management of complications a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86.
 
4) Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
 
5) Singer M, Deutschman CS, Seymour CW, et al. The Third International consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10.
 
6) Garcia RA, Spitzer ED, Beaudry J, et al. Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line-associated bloodstream infections. Am J Infect Control. 2015;43(11):1222-37.
 
7) National Health Service, Department of Health, United Kingdom. Taking blood cultures:a summary of best practice. Available from:http://webarchive.nationalarchives.gov.uk/20120118164404/hcai.dh.gov.uk/files/2011/03/Document_Blood_culture_FINAL_100826.pdf. Accessed July 7, 2016.
 
8) Tokuda Y, Miyasato H, Stein GH, The degree of chills for risk of bacteremia in acute febrile illness. Am J Med. 2005;118(12):1417.
 
9) Riedel S, Bourbeau P, Swartz B, et al. Iming of specimen collection for blood cultures from febrile patients with bacteremia. J Clin Microbiol. 2008;46(4):1381-5.
 
10) Clinical and laboratory Standards Institute (CLSI). Principles and procedures for blood cultures:approved guideline. CLSI document M47-A. Wayne (PA):Clinical and Laboratory Standards Institute;2007.
 
11) Baron EJ, Miller JM, Weinstein MP, et al. Executive summary:a guide to utilization of the microbiology laboratory for diagnosis ofinfectious diseases:2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2013;57(4):485-8.
 
12) Cockerill FR 3rd, Wilson JW, Vetter EA, et al. Optimal testing parameters for blood cultures. Clin Infect Dis. 2004;38(12):1724-30.
 
13) Gonsalves WI, Cornish N, Moore M, et al. Effects of volume and site of blood draw on blood culture results. J Clin Microbiol. 2009;47(11):3482-5.
 
14) Lee A, Mirrett S, Reller LB, et al. Detection of bloodstream infections in adults:how many blood cultures are needed? J Clin Microbiol. 2007;45(11):3546-8.
 
15) Li J, Plorde JJ, Carlson LG. Effects of volume and periodicity on blood cultures. J Clin Microbiol. 1994;32(11):2829-31.
 
16) Alcorn K, Meier FA, Schifman RB. Blood culture contamination. Q-Tracks 2013 monitor instructions. Northfield, IL:College of American Pathologists;2013.
 
17) Schifman RB, Strand CL, Meier FA, et al. Blood culture contamination:a College of American Pathologists Q-Probes study involving 640 institutions and 497,134 specimens from adult patients. Arch Pathol Lab Med. 1998;122:216-21.
 
18) Bekeris LG, Tworek JA, Walsh MK, et al. Trends in blood culture contamination:a College of American Pathologists Q-Tracks Study of 356 institutions. Arch Pathol Lab Med. 2005;129:1222-5.
 
19) Edmond MB, Wenzel RP. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition, 300, 3286-93.e1.
 
20) Kassis C, Rangaraj G, Jiang Y, et al. Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol. 2009;47(10):3255-60.
 
21) Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
 
22) Little JR, Murray PR, Traynor PS, et al. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection:effects on rates of blood culture contamination. Am J Med. 1999;107(2):119-25.
 
23) Mimoz O, Karim A, Mercat A, et al. Chlorhexidine compared with povidone-iodine as skin preparation before blood culture. A randomized, controlled trial. Ann Intern Med. 1999;131(11):834-7.
 
24) Calfee DP, Farr BM. Comparison of four antiseptic preparations for skin in the prevention of contamination of percutaneously drawn blood cultures:a randomized trial. J Clin Microbiol. 2002;40(5):1660-5.
 
25) Washer LL, Chenoweth C, Kim HW, et al. Blood culture contamination:a randomized trial evaluating the comparative effectiveness of 3 skin antiseptic interventions. Infect Control Hosp Epidemiol. 2013;34:15-21.
 
26) Weinstein MP. Blood culture contamination:persisting problems and partial progress. J Clin Microbiol. 2003;41(6):2275-8.
 
27) Weinbaum FI, Lavie S, Danek M, et al. Doing it right the first time:quality improvement and the contaminant blood culture. J Clin Microbiol. 1997;35(3):563-5.
 
28) Kim NH, Kim M, Lee S, et al. Effect of routine sterile gloving on contamination rates in blood culture. Ann Intern Med. 2011;154:145-51.
 
29) Snyder SR, Favoretto AM, Baetz RA, et al. Effectiveness of practices to reduce blood culture contamination:a laboratory medicine best practices systematic review and meta-analysis. Clin Biochem. 2012;45:999-1011.
 
30) Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006;19:788-802.
 
31) Wilson ML, Mirrett S, Reller LB, et al. Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis. 1993;16(1):31-4.
 
32) Bourbeau PP, Foltzer M. Routine incubation of BacT/ALERT FA and FN blood culture bottles for more than 3 days may not be necessary. J Clin Microbiol. 2005;43(5):2506-9.
 
33) Raad I, Hanna HA, Alakech B, et al. Differential time to positivity:a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med. 2004;140(1):18-25.
 
34) Ruiz-Giardin JM, Martin-Diaz RM, Jaqueti-Aroca J, et al. Diagnosis of bacteraemia and growth times. Int J Infect Dis. 2015;41:6-10.
 
35) Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s:a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584-602.
 
36) Spitalnic SJ, Woolard RH, Mermel LA. The significance of changing needles when inoculating blood cultures:a meta-analysis. Clin Infect Dis. 1995;21(5):1103-6.
 
P.151 掲載の参考文献
1) Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
 

6 胸水貯留患者の診断アプローチ 胸水穿刺はBecause it's there

P.177 掲載の参考文献
1) Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006;73(7):1211-20.
 
2) Blackmore CC, Black WC, Dallas RV, et al. Pleural fluid volume estimation:a chest radiograph prediction rule. Acad Radiol. 1996;3(2):103-9.
 
3) McGrath EE, Anderson PB. Diagnosis of pleural effusion:a systematic approach. Am J Crit Care. 2011;20(2):119-27;quiz 128.
 
4) Hooper C, Lee YC, Maskell N;BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults:British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 Suppl 2:ii4-17.
 
5) Ferreiro L, San Jose ME, Gude F, et al. Unilateral or Bilateral Thoracocentesis for Bilateral Pleural Effusion. A Prospective Study. Arch Bronconeumol. 2016;52(4):189-95.
 
6) Wong CL, Holroyd-Leduc J, Straus SE. Does this patient have a pleural effusion? JAMA. 2009;301(3):309-17.
 
7) Cardenas A, Kelleher T, Chopra S. Review article:hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20(3):271-9.
 
8) Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011;66(8):658-62.
 
9) Porcel JM, Vives M. Classic, abbreviated, and modified Light's criteria:the end of the story? Chest. 1999;116(6):1833-6.
 
10) Romero-Candeira S, Fernandez C, Martin C, et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med. 2001;110(9):681-6.
 
11) Burgess LJ, Maritz FJ, Taljaard JJ. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest. 1995;107(6):1604-9.
 
12) Heffner JE, Highland K, Brown LK. A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates. Am J Respir Crit Care Med. 2003;167(12):1591-9.
 
13) Zablockis R, Nargela R. Diagnostic value of pleural fluid cytologic examination. Medicina (Kaunas). 2002;38(12):1171-8.
 
14) Ozkara SK, Turan G, Basyigit I. Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol. 2007;51(5):773-81.
 
15) Good JT Jr, Taryle DA, Maulitz RM, et al. The diagnostic value of pleural fluid pH. Chest. 1980;78(1):55-9.
 
16) Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med. 1988;108(3):345-9.
 
17) Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest. 2000;117(1):79-86.
 
18) Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151(6):1700-8.
 
19) Rahman NM, Mishra EK, Davies HE, et al. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med. 2008;178(5):483-90.
 
20) Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol. 1994;7(6):665-8.
 
21) Swiderek J, Morcos S, Donthireddy V, et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest. 2010;137(1):68-73.
 
22) Sahn SA. State of the art. The pleura. Am Rev Respir Dis. 1988;138(1):184-234.
 
23) Joseph J, Viney S, Beck P, et al. A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis. Chest. 1992;102(5):1455-9.
 
24) Sherr HP, Light RW, Merson MH, et al. Origin of pleural fluid amylase in esophageal rupture. Ann Intern Med. 1972;76(6):985-6.
 
25) Kramer MR, Saldana MJ, Cepero RJ, et al. High amylase levels in neoplasm-related pleural effusion. Ann Intern Med. 1989;110(7):567-9.
 
26) Branca P, Rodriguez RM, Rogers JT, et al. Routine measurement of pleural fluid amylase is not indicated. Arch Intern Med. 2001;161(2):228-32.
 
27) Lankisch PG, Droge M, Becher R. Pleural effusions:a new negative prognostic parameter for acute pancreatitis. Am J Gastroenterol. 1994;89(10):1849-51.
 
28) Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest. 2004;126(6):1757-63.
 
29) Shitrit D, Zingerman B, Shitrit AB, et al. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions:analysis of 116 cases and review of the literature. Oncologist. 2005;10(7):501-7.
 
30) Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990;154(3):487-92.
 
31) Waite RJ, Carbonneau RJ, Balikian JP, et al. Parietal pleural changes in empyema:appearances at CT. Radiology. 1990;175(1):145-50.
 
32) Huang HC, Chang HY, Chen CW, et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest. 1999;115(3):751-6.
 
33) Escudero Bueno C, Garcia Clemente M, Cuesta Castro B, et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Study of 414 patients. Arch Intern Med. 1990;150(6):1190-4.
 
34) Diacon AH, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy:a direct comparative study. Eur Respir J. 2003;22(4):589-91.
 
35) Neves DD, Dias RM, da Cunha AJ, et al. What is the probability of a patient presenting a pleural effusion due to tuberculosis? Braz J Infect Dis. 2004;8(4):311-8. Epub 2004 Nov 19.
 
36) Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy:a meta-analysis. Respir Med. 2008;102(5):744-54.
 
37) Meneses PL, Barrioz DD, Rivera CG, et al. Mayoralas Alises. Very High Level Of Adenosin Deaminasa (ADA) In Pleural Effusions, Uncommon In Tuberculosis. ATS 2013. 2013;Poster Discussion.
 
38) Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest. 1993;103(2):458-65.
 
39) Jiang J, Shi HZ, Liang QL, et al. Diagnostic value of interferon-gamma in tuberculous pleurisy:a metaanalysis. Chest. 2007;131(4):1133-41.
 
40) Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45(11):1480-6.
 
41) Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. QJM. 1996;89(4):285-9.
 
42) Ferreiro L, Alvarez-Dobano JM, Valdes L. Systemic diseases and the pleura. Arch Bronconeumol. 2011;47(7):361-70.
 
43) Balbir-Gurman A, Yigla M, Nahir AM, et al. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006;35(6):368-78.
 
44) Pettersson T, Klockars M, Hellstrom PE. Chemical and immunological features of pleural effusions:comparison between rheumatoid arthritis and other diseases. Thorax. 1982;37(5):354-61.
 
45) Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis. 1979;119(3):471-503.
 
46) Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest. 1991;100(3):598-603.
 
47) Porcel JM, Madronero AB, Pardina M, et al. Analysis of pleural effusions in acute pulmonary embolism:radiological and pleural fluid data from 230 patients. Respirology. 2007;12(2):234-9.
 
48) Doerr CH, Allen MS, Nichols FC 3rd, et al. Etiology of chylothorax in 203 patients. Mayo Clin Proc. 2005;80(7):867-70.
 
49) Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA. 1982;247(5):617-22.
 
50) Hillerdal G, Ozesmi M. Benign asbestos pleural effusion:73 exudates in 60 patients. Eur J Respir Dis. 1987;71(2):113-21.
 
51) Robinson BW, Musk AW. Benign asbestos pleural effusion:diagnosis and course. Thorax. 1981;36(12):896-900.
 
52) Fujimoto N, Gemba K, Asano M, et al. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma. Respir Investig. 2013;51(2):92-7.
 
53) Venekamp LN, Velkeniers B, Noppen M. Does 'idiopathic pleuritis' exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy. Respiration. 2005;72(1):74-8.
 
55) Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest. 1989;95(5):945-7.
 
P.183 掲載の参考文献
1) Guarino JR, Guarino JC. Auscultatory percussion:a simple method to detect pleural effusion. J Gen Intern Med. 1994;9(2):71-4.
 
2) Kalantri S, Joshi R, Lokhande T, et al. Accuracy and reliability of physical signs in the diagnosis of pleural effusion. Respir Med. 2007;101(3):431-8. Epub 2006 Sep 11.
 
3) Wong CL, Holroyd-Leduc J, Straus SE. Does this patient have a pleural effusion? JAMA. 2009;301(3):309-17.
 

7 腹水貯留患者の診断アプローチ

P.206 掲載の参考文献
1) Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117(3):215-20.
 
2) Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system:portal hypertension-2. Ascites, encephalopathy, and other conditions. BMJ. 2001;322(7283):416-8.
 
3) Tarn AC, Lapworth R. Biochemical analysis of ascitic (peritoneal) fluid:what should we measure? Ann Clin Biochem. 2010;47(Pt 5):397-407.
 
4) Williams JW Jr, Simel DL. The rational clinical examination. Does this patient have ascites? How to divine fluid in the abdomen. JAMA. 1992;267(19):2645-8.
 
5) Runyon BA;AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651-3.
 
6) Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258-66.
 
7) Stanley MM, Ochi S, Lee KK, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans administration cooperative study on treatment of alcoholic cirrhosis with ascites. N Engl J Med. 1989;321(24):1632-8.
 
8) Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis:a multicentre prospective study. Dig Liver Dis. 2001;33(1):41-8.
 
9) Kim JJ, Tsukamoto MM, Mathur AK, et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109(9):1436-42.
 
10) Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146(11):2259-61.
 
11) Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40(2):484-8.
 
12) Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease:are they related? No. J Thromb Haemost. 2006;4(4):721-3.
 
13) Runyon BA. Evaluation of adults with ascites. UpToDate.
 
14) Chinnock B, Hendey GW. Can clear ascitic fluid appearance rule out spontaneous bacterial peritonitis? Am J Emerg Med. 2007;25(8):934-7.
 
15) Runyon BA, Akriviadis EA, Keyser AJ. The opacity of portal hypertension-related ascites correlates with the fluid's triglyceride concentration. Am J Clin Pathol. 1991;96(1):142-3.
 
16) Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med. 1982;96(3):358-64.
 
17) Rector WG Jr. Spontaneous chylous ascites of cirrhosis. J Clin Gastroenterol. 1984;6(4):369-72.
 
18) DeSitter L, Rector WG Jr. The significance of bloody ascites in patients with cirrhosis. Am J Gastroenterol. 1984;79(2):136-8.
 
19) Runyon BA. Ascitic fluid bilirubin concentration as a key to choleperitoneum. J Clin Gastroenterol. 1987;9(5):543-5.
 
20) Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142-53.
 
21) Hoefs JC. Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease. Hepatology. 1981;1(3):249-54.
 
22) Runyon BA, Hoefs JC. Ascitic fluid chemical analysis before, during and after spontaneous bacterial peritonitis. Hepatology. 1985;5(2):257-9.
 
23) Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 1986;91(6):1343-6.
 
24) Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990;98(1):127-33.
 
25) Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology. 1988;95(5):1351-5.
 
26) Chinnock B, Fox C, Hendey GW. Gram's stain of peritoneal fluid is rarely helpful in the evaluation of the ascites patient. Ann Emerg Med. 2009;54(1):78-82.
 
27) Runyon BA, Umland ET, Merlin T. Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis. Arch Intern Med. 1987;147(1):73-5.
 
28) Bobadilla M, Sifuentes J, Garcia-Tsao G. Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. J Clin Microbiol. 1989;27(10):2145-7.
 
29) Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology. 1984;4(3):447-50.
 
30) Lee HH, Carlson RW, Bull DM. Early diagnosis of spontaneous bacterial peritonitis:values of ascitic fluid variables. Infection. 1987;15(4):232-6.
 
31) Wilson JA, Suguitan EA, Cassidy WA, et al. Characteristics of ascitic fluid in the alcoholic cirrhotic. Dig Dis Sci. 1979;24(8):645-8.
 
32) Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels. Arch Intern Med. 1978;138(7):1103-5.
 
33) Runyon BA. Amylase levels in ascitic fluid. J Clin Gastroenterol. 1987;9(2):172-4.
 
34) Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8(5):1104-9.
 
35) DiBonito L, Falconieri G, Colautti I, et al. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol. 1993;37(4):483-8.
 
36) Gulyas M, Kaposi AD, Elek G, et al. Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology. J Clin Pathol. 2001;54(11):831-5.
 
37) Wu SS, Lin OS, Chen YY, et al. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary fromsecondary bacterial peritonitis with intestinal perforation. J Hepatol. 2001;34(2):215-21.
 
38) Prieto M, Gomez-Lechon MJ, Hoyos M, et al. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference. Dig Dis Sci. 1988;33(7):833-8.
 
39) Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis. 1998;27:669-74.
 
40) Caruntu FA, Benea L. Spontaneous bacterial peritonitis:pathogenesis, diagnosis, treatment. J Gastrointestin Liver Dis. 2006;15(1):51-6.
 
41) Wong CL, Holroyd-Leduc J, Thorpe KE, et al. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA. 2008;299(10):1166-78.
 
42) Parsi MA, Atreja A, Zein NN. Spontaneous bacterial peritonitis:recent data on incidence and treatment. Cleve Clin J Med. 2004;71(7):569-76.
 
43) Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med. 2003;31(8):2228-37.
 
44) Sanai FM, Bzeizi KI. Systematic review:tuberculous peritonitis--presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22(8):685-700.
 
45) Srivastava U, Almusa O, Tung KW, et al. Tuberculous peritonitis. Radiol Case Rep. 2015;9(3):971.
 
46) Dwivedi M, Misra SP, Misra V, et al. Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites. Am J Gastroenterol. 1990;85(9):1123-5.
 
47) Chinnock B, Afarian H, Minnigan H, et al. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis. Ann Emerg Med. 2008;52(3):268-73.
 

8 髄膜炎患者の診断アプローチ 慌てず, 焦らず, 急ぐ

P.255 掲載の参考文献
1) 「細菌性髄膜炎診療ガイドライン」作成委員会. 細菌性髄膜炎診療ガイドライン2014. 南江堂;2014.
 
2) Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis:the PNEUMOREA prospective multicenter study. Crit Care Med. 2006;34(11):2758-65.
 
3) van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-59.
 
4) Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-84.
 
5) Bartt R. Acute bacterial and viral meningitis. Continuum (Minneap Minn). 2012;18(6 Infectious Disease):1255-70.
 
6) Attia J, Hatala R, Cook DJ, et al. The rational clinical examination. Does this adult patient have acute meningitis? JAMA. 1999;282(2):175-81.
 
7) Brouwer MC, Thwaites GE, Tunkel AR, et al. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet. 2012;380(9854):1684-92.
 
8) Uchihara T, Tsukagoshi H. Jolt accentuation of headache:the most sensitive sign of CSF pleocytosis. Headache. 1991;31(3):167-71.
 
9) Tamune H, Takeya H, Suzuki W, et al. Absence of jolt accentuation of headache cannot accurately rule out meningitis in adults. Am J Emerg Med. 2013;31(11):1601-4.
 
10) Nakae Y, Kuroiwa Y. Sensitivity and specificity of jolt accentuation of headache in meningitis. Japanese J Headache (Japanese). 2008;35:133.
 
11) Aminzadeh Z, Roudgari A. Jolt accentuation of headache in diagnosis of acute meningitis. Iranian J Clin Infect Dis. 2010;5:106-9.
 
12) Waghdhare S, Kalantri A, Joshi R, et al. Accuracy of physical signs for detecting meningitis:a hospital-based diagnostic accuracy study. Clin Neurol Neurosurg. 2010;112(9):752-7.
 
13) Straus SE, Thorpe KE, Holroyd-Leduc J. How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis? JAMA. 2006;296(16):2012-22.
 
14) Flaatten H, Krakenes J, Vedeler C. Post-dural puncture related complications after diagnostic lumbar puncture, myelography and spinal anaesthesia. Acta Neurol Scand. 1998;98(6):445-51.
 
15) Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345(24):1727-33.
 
16) Glimaker M, Johansson B, Grindborg O, et al. Adult bacterial meningitis:earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis. 2015;60(8):1162-9.
 
17) Ruff RL, Dougherty JH Jr. Complications of lumbar puncture followed by anticoagulation. Stroke. 1981;12(6):879.
 
18) Horlocker TT. Low molecular weight heparin and neuraxial anesthesia. Thromb Res. 2001;101(1):V141.
 
19) Layton KF, Kallmes DF, Horlocker TT. Recommendations for anticoagulated patients undergoing image-guided spinal procedures. AJNR Am J Neuroradiol. 2006;27(3):468.
 
20) van Veen JJ, Nokes TJ, Makris M. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol. 2010;148(1):15.
 
21) Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80(2):303.
 
22) Chakraverty R, Pynsent P, Isaacs K. Which spinal levels are identified by palpation of the iliac crests and the posterior superior iliac spines? J Anat. 2007;210(2):232-6.
 
23) Armon C, Evans RW;Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Addendum to assessment:Prevention of post-lumbar puncture headaches:report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65(4):510-2.
 
24) Strupp M, Brandt T, Muller A. Incidence of post-lumbar puncture syndrome reduced by reinserting the stylet:a randomized prospective study of 600 patients. J Neurol. 1998;245(9):589-92.
 
25) Tourtellotte WW, Henderson WG, Tucker RP, et al. A randomized, double-blind clinical trial comparing the 22 versus 26 gauge needle in the production of the post-lumbar puncture syndrome in normal individuals. Headache. 1972;12(2):73-8.
 
26) Arevalo-Rodriguez I, Ciapponi A, Roque i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016;3:CD009199.
 
27) Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328(1):21-8.
 
28) Seehusen DA, Reeves MM, Fomin DA. Cerebrospinal fluid analysis. Am Fam Physician. 2003;68(6):1103-8.
 
29) Steele RW, Marmer DJ, O'Brien MD. Leukocyte survival in cerebrospinal fluid. J Clin Microbiol. 1986;23(5):965-6.
 
30) Schmidley JW, Simon RP. Postictal pleocytosis. Ann Neurol. 1981;9(1):81-4.
 
31) Viallon A, Desseigne N, Marjollet O, et al. Meningitis in adult patients with a negative direct cerebrospinal fluid examination:value of cytochemical markers for differential diagnosis. Crit Care. 2011;15(3):R136.
 
32) Huy NT, Thao NT, Diep DT, et al. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis:a systemic review and meta-analysis. Crit Care. 2010;14(6):R240.
 
33) Sakushima K, Hayashino Y, Kawaguchi T, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis:a meta-analysis. J Infect. 2011;62(4):255-62.
 
34) Leib SL, Boscacci R, Gratzl O. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis. 1999;29(1):69-74.
 
35) de Gans J, van de Beek D;European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549-56.
 
36) Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis:risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129(11):862-9.
 
37) Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev. 1992;5(2):130-45.
 
38) Shanholtzer CJ, Schaper PJ, Peterson LR. Concentrated gram stain smears prepared with a cytospin centrifuge. J Clin Microbiol. 1982;16(6):1052-6.
 
39) Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467-92.
 
40) Tunkel AR, van de Beek D, Scheld WM. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition. Elsevier;2015. p.89, 1097-137.e8.
 
41) Adriani KS, Brouwer MC, van de Beek D. Risk factors for community-acquired bacterial meningitis in adults. Neth J Med. 2015;73(2):53-60.
 
42) Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report, Emerging Infections Program Network Streptococcus pneumoniae, 2010. Available at:http://www.cdc.gov/abcs/reports-findings/survreports/spneu10-orig.pdf
 
43) Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries:a systematic review and meta-analysis. J Infect. 2010;61(2):114-24.
 
44) Wolf RE, Birbara CA. Meningococcal infections at an army training center. Am J Med. 1968;44(2):243-55.
 
45) Clauss HE, Lorber B. Central nervous system infection with Listeria monocytogenes. Curr Infect Dis Rep. 2008;10(4):300-6.
 
46) Siegman-Igra Y, Bar-Yosef S, Gorea A, et al. Nosocomial acinetobacter meningitis secondary to invasive procedures:report of 25 cases and review. Clin Infect Dis. 1993;17(5):843-9.
 
47) Bartt R. Acute bacterial and viral meningitis. Continuum (Minneap Minn). 2012;18(6 Infectious Disease):1255-70.
 
48) Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144-9.
 
49) Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707-11.
 
50) Wildemann B, Ehrhart K, Storch-Hagenlocher B, et al. Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology. 1997;48(5):1341-6.
 
51) Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis:application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995;171(4):857-63.
 
52) Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system:therapeutic and diagnostic considerations. Clin Infect Dis. 1995;20(2):414-20.
 
53) Abou-Foul AK, Buhary TM, Gayed SL. Herpes simplex virus type 2-associated recurrent aseptic (Mollaret's) meningitis in genitourinary medicine clinic:a case report. Int Med Case Rep J. 2014;7:31-3.
 
54) van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146-54.
 
55) Kourbeti IS, Jacobs AV, Koslow M, et al. Risk factors associated with postcraniotomy meningitis. Neurosurgery. 2007;60(2):317-25;discussion 325-6.
 
56) Conen A, Walti LN, Merlo A, et al. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults:a retrospective analysis over an 11-year period. Clin Infect Dis. 2008;47(1):73-82.
 
57) Szvalb AD, Raad II, Weinberg JS, et al. Ommaya reservoir-related infections:clinical manifestations and treatment outcomes. J Infect. 2014;68(3):216-24.
 
58) Safdieh JE, Mead PA, Sepkowitz KA, et al. Bacterial and fungal meningitis in patients with cancer. Neurology. 2008;70(12):943-7.
 
59) Leib SL, Boscacci R, Gratzl O, et al. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis. 1999;29(1):69-74.
 
60) Zunt JR, Baldwin KJ. Chronic and subacute meningitis. Continuum (Minneap Minn). 2012;18(6 Infectious Disease):1290-318.
 
61) Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii:separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol. 1999;37(3):838-40.
 
62) Nakao M, Muramatsu H, Takahashi T, et al. Cryptococcus gattii Genotype VGIIa Infection in an Immunocompetent Japanese Patient:A Case Report and Mini-review. Intern Med. 2016;55(20):3021-4.
 
63) Day J. Cryptococcal meningitis. Pract Neurol. 2004;4:274-85.
 
64) Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994;32(7):1680-4.
 
65) Antinori S, Corbellino M, Meroni L, et al. Aspergillus meningitis:a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect. 2013;66(3):218-38.
 
66) Verweij PE, Brinkman K, Kremer HP, et al. Aspergillus meningitis:diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol. 1999;37(4):1186-9.
 
67) Golden MR, Marra CM, Holmes KK. Update on syphilis:resurgence of an old problem. JAMA. 2003;290(11):1510-4.
 
68) Vanhaecke C, Grange P, Benhaddou N, et al;Neurosyphilis Network;Neurosyphilis network. Clinical and Biological Characteristics of 40 Patients With Neurosyphilis and Evaluation of Treponemapallidum Nested Polymerase Chain Reaction in Cerebrospinal Fluid Samples. Clin Infect Dis. 2016;63(9):1180-6.
 
69) Jacob JT, Mehta AK, Leonard MK. Acute forms of tuberculosis in adults. Am J Med. 2009;122(1):12-7.
 
70) 亀井聡, 三木健司, 荒木俊彦, 他;日本神経治療学会治療指針作成委員会. 標準的神経治療 結核性髄膜炎. 神経治療学(0916-8443). 2015;32(4):511-32.
 
71) Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis:a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-12.
 
72) Thwaites GE, Tran TH. Tuberculous meningitis:many questions, too few answers. Lancet Neurol. 2005;4(3):160-70.
 
73) Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis:a systematic review and meta-analysis. Lancet Infect Dis. 2003;3(10):633-43.
 
74) Takahashi T, Tamura M, Asami Y, et al. Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA:clinical application for diagnosis of tuberculous meningitis. J Clin Microbiol. 2008;46(5):1698-707.
 
75) Tuon FF, Higashino HR, Lopes MI, et al. Adenosine deaminase and tuberculous meningitis--a systematic review with meta-analysis. Scand J Infect Dis. 2010;42(3):198-207.
 
76) Forgacs P, Geyer CA, Freidberg SR. Characterization of chemical meningitis after neurological surgery. Clin Infect Dis. 2001;32(2):179-85.
 

9 関節炎患者の診断アプローチ 化膿性関節炎を見逃さない

P.289 掲載の参考文献
1) Horowitz DL, Katzap E, Horowitz S, et al. Approach to septic arthritis. Am Fam Physician. 2011;84(6):653-60.
 
2) Mathews CJ, Weston VC, Jones A, et al. Bacterial septic arthritis in adults. Lancet. 2010;375(9717):846-55.
 
3) Ensworth S. Rheumatology:1. Is it arthritis? CMAJ. 2000;162(7):1011-6.
 
4) 上野征夫. リウマチ病診療ビジュアルテキスト. 第2版. 医学書院;2008.
 
5) Mies Richie A, Francis ML. Diagnostic approach to polyarticular joint pain. Am Fam Physician. 2003;68(6):1151-60.
 
6) Freemont AJ. Microscopic analysis of synovial fluid--the perfect diagnostic test? Ann Rheum Dis. 1996;55(10):695-7.
 
7) Kerolus G, Clayburne G, Schumacher HR Jr. Is it mandatory to examine synovial fluids promptly after arthrocentesis? Arthritis Rheum. 1989;32(3):271-8.
 
8) Siva C, Velazquez C, Mody A, et al. Diagnosing acute monoarthritis in adults:a practical approach for the family physician. Am Fam Physician. 2003;68(1):83-90.
 
9) Margaretten ME, Kohlwes J, Moore D, et al. Does this adult patient have septic arthritis? JAMA. 2007;297(13):1478-88.
 
10) Shmerling RH, Delbanco TL, Tosteson AN, et al. Synovial fluid tests. What should be ordered? JAMA. 1990;264(8):1009-14.
 
11) Dougados M. Synovial fluid cell analysis. Baillieres Clin Rheumatol. 1996;10(3):519-34.
 
12) Kay J, Eichenfield AH, Athreya BH, Synovial fluid eosinophilia in Lyme disease. Arthritis Rheum. 1988;31(11):1384-9.
 
13) Carpenter CR, Schuur JD, Everett WW, et al. Evidence-based diagnostics:adult septic arthritis. Acad Emerg Med. 2011;18(8):781-96.
 
14) Wise CM, Morris CR, Wasilauskas BL, Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med. 1994;154(23):2690-5.
 
15) Courtney P, Doherty M. Joint aspiration and injection and synovial fluid analysis. Best Pract Res Clin Rheumatol. 2013;27(2):137-69.
 
16) von Essen R, Holtta A. Improved method of isolating bacteria from joint fluids by the use of blood culture bottles. Ann Rheum Dis. 1986;45(6):454-7.
 
17) Swan A, Amer H, Dieppe P. The value of synovial fluid assays in the diagnosis of joint disease:a literature survey. Ann Rheum Dis. 2002;61(6):493-8.
 
18) Kaandorp CJ, Dinant HJ, van de Laar MA, et al. Incidence and sources of native and prosthetic joint infection:a community based prospective survey. Ann Rheum Dis. 1997;56(8):470-5.
 
19) Weston VC, Jones AC, Bradbury N, et al. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis. 1999;58(4):214-9.
 
20) Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology (Oxford). 2001;40(1):24-30.
 
21) Ryan MJ, Kavanagh R, Wall PG, et al. Bacterial joint infections in England and Wales:analysis of bacterial isolates over a four year period. Br J Rheumatol. 1997;36(3):370-3.
 
22) Liebling MR, Arkfeld DG, Michelini GA, et al. Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum. 1994;37(5):702-9.
 
23) Gardam M, Lim S. Mycobacterial osteomyelitis and arthritis. Infect Dis Clin North Am. 2005;19(4):819-30.
 
24) Osmon DR, Berbari EF, Berendt AR, et al;Infectious Diseases Society of America. Executive summary:diagnosis and management of prosthetic joint infection:clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):1-10.
 
25) Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection:case-control study. Clin Infect Dis. 1998;27(5):1247-54.
 
26) Trampuz A, Hanssen AD, Osmon DR, et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med. 2004;117(8):556.
 
27) Ghanem E, Parvizi J, Burnett RS, et al. Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am. 2008;90(8):1637.
 
28) Pittman JR, Bross MH. Diagnosis and management of gout. Am Fam Physician. 1999;59(7):1799-806, 1810.
 
29) Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease. N Engl J Med. 2016;374(26):2575-84.
 
30) Masuda I, Ishikawa K. Clinical features of pseudogout attack. A survey of 50 cases. Clin Orthop Relat Res. 1988;(229):173-81.
 
31) Godfrin-Valnet M, Godfrin G, Godard J, et al. Eighteen cases of crowned dens syndrome:Presentation and diagnosis. Neurochirurgie. 2013;59(3):115-20.
 
32) Neame RL, Carr AJ, Muir K, et al. UK community prevalence of knee chondrocalcinosis:evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62(6):513-8.
 
33) Wilkins E, Dieppe P, Maddison P, et al. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis. 1983;42(3):280-4.
 
34) Stavropoulos PG, Soura E, Kanelleas A, et al. Reactive arthritis. J Eur Acad Dermatol Venereol. 2015;29(3):415-24.
 
35) Bernini L, Manzini CU, Giuggioli D, et al. Reactive arthritis induced by intravesical BCG therapy for bladder cancer:our clinical experience and systematic review of the literature. Autoimmun Rev. 2013;12(12):1150-9.
 
36) Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011;25(3):347-57.
 

10 感染症診療におけるバイオマーカーの運用 CRPと周辺のバイオマーカーについて

P.311 掲載の参考文献
1) Tillett WS, Francis T Jr. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52:561-71.
 
2) Litao MK, Kamat D. Erythrocyte sedimentation rate and C-reactive protein:how best to use them in clinical practice. Pediatr Ann. 2014;43(10):417-20.
 
3) Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16(8):735-46;quiz 746-7.
 
4) Silvestre JP, Coelho LM, Povoa PM. Impact of fulminant hepatic failure in C-reactive protein? J Crit Care. 2010;25(4):657.e7-12.
 
5) Ugarte H, Silva E, Mercan D, et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27(3):498-504.
 
6) Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11(2):101-8.
 
7) Povoa P, Coelho L, Almeida E, et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein:a prospective observational study. Crit Care. 2006;10(2):R63.
 
8) Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-17.
 
9) Zhang Z, Ni H. C-reactive protein as a predictor of mortality in critically ill patients:a meta-analysis and systematic review. Anaesth Intensive Care. 2011;39(5):854-61.
 
10) Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123(6):2043-9.
 
11) Reny JL, Vuagnat A, Ract C, et al. Diagnosis and follow-up of infections in intensive care patients:value of C-reactive protein compared with other clinical and biological variables. Crit Care Med. 2002;30(3):529-35.
 
12) Schmit X, Vincent JL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection. 2008;36(3):213-9.
 
13) Davies J. Procalcitonin. J Clin Pathol. 2015;68(9):675-9.
 
14) Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and macrophage-activated adipocytes. Crit Care Med. 2004;8:1715-24.
 
15) Henriquez-Camacho C, Losa J. Biomarkers of sepsis. Biomed Res Int. 2014;2014:547818.
 
16) Fan SL, Miller NS, Lee J, et al. Diagnosing sepsis - The role of laboratory medicine. Clin Chim Acta. 2016;460:203-10.
 
17) Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis:a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-35.
 
18) Anand D, Das S, Bhargava S, et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome:a prospective, observational, cohort study. J Crit Care. 2015;30(1):218.e7-12.
 
19) Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions:a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322-31.
 
20) Sridharan P, Chamberlain RS. The efficacy of procalcitonin as a biomarker in the management of sepsis:slaying dragons or tilting atwindmills? Surg Infect (Larchmt). 2013;14(6):489-511.
 
21) Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23-36.
 
22) Christ-Crain M, Muller B. Procalcitonin in bacterial infections--hype, hope, more or less? Swiss Med Wkly. 2005;135(31-32):451-60.
 
23) Grzybowski A, Sak JJ. Who discovered the erythrocyte sedimentation rate? J Rheumatol. 2011;38(7):1521-2;author reply 1523.
 
24) Kamath S, Lip GY. Fibrinogen:biochemistry, epidemiology and determinants. QJM. 2003;96(10):711-29.
 
25) Jurado RL. Why shouldn't we determine the erythrocyte sedimentation rate? Clin Infect Dis. 2001;33(4):548-9.
 
26) Feldman M, Aziz B, Kang GN, et al. C-reactive protein and erythrocyte sedimentation rate discordance:frequency and causes in adults. Transl Res. 2013;161(1):37-43.
 
27) Lin Z, Vasudevan A, Tambyah PA. Use of erythrocyte sedimentation rate and C-reactive protein to predict osteomyelitis recurrence. J Orthop Surg (Hong Kong). 2016;24(1):77-83.
 
28) Crosby LA, Powell DA. The potential value of the sedimentation rate in monitoring treatment outcome in puncture-wound-related Pseudomonas osteomyelitis. Clin Orthop Relat Res. 1984;(188):168-72.
 
29) 福井次矢, 黒川清. ハリソン内科学, 第3版. 東京:メディカルサイエンス・インターナショナル;2009. p.388-97.
 
30) Kapasi AJ, Dittrich S, Gonzalez IJ, et al. Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness:A Comprehensive Review. PLoS One. 2016;11(8):e0160278.
 
31) Coates TD. Approach to the patient with neutrophilia. UP-TO-DATE.
 
32) Berliner N. Approach to the adult with unexplained neutropenia. UP-TO-DATE.
 
33) Berliner N. Approach to the adult with lymphocytosis or lymphocytopenia. UP-TO-DATE.
 
34) Weller PF. Approach to the patient with unexplained eosinophilia. UP-TO-DATE.
 
35) Seigel TA, Cocchi MN, Salciccioli J, et al. Inadequacy of temperature and white blood cell count in predicting bacteremia in patients with suspected infection. J Emerg Med. 2012;42(3):254-9.
 
36) Drees M, Kanapathippillai N, Zubrow MT. Bandemia with normal white blood cell counts associated with infection. Am J Med. 2012;125(11):1124.e9-1124.e15.
 
37) de Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192.
 
38) Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539-48.
 
39) Kiriyama S, Takada T, Strasberg SM, et al;Tokyo Guidelines Revision Committee. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19(5):548-56.
 
40) Yokoe M, Takada T, Strasberg SM, et al;Tokyo Guidelines Revision Committee. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19(5):578-85.
 
41) Freifeld AG, Bow EJ, Sepkowitz KA, et al;Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer:2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56-93.
 
42) 日本呼吸器学会市中肺炎診療ガイドライン作成委員会, 編. 成人市中肺炎診療ガイドライン. 東京:日本呼吸器学会;2007.
 
43) Ishida T, Miyashita N, Nakahama C. Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology. 2007;12(1):104-10.
 
44) Bari SF, Khan A, Lawson T. C reactive protein may not be reliable as a marker of severe bacterial infection in patients receiving tocilizumab. BMJ Case Rep. 2013;2013.
 
45) Choi CM, Kang CI, Jeung WK, et al. Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int J Tuberc Lung Dis. 2007;11(2):233-6.
 
46) 伊藤邦彦, 吉山 崇, 和田雅子, 他. 肺結核診断における炎症反応測定の意義. 結核. 2004;79(4):309-11.
 

11 術後患者の発熱の診断アプローチ 発症時期と病因を主軸に考える

P.339 掲載の参考文献
1) Nadene C. Postoperative Fevers. Hospital Medicine Clinics. 2012;1(4):e457-70.
 
2) House J, Alexandraki I. Postoperative fever. BMJ Best Practice. 2012.
 
3) Dauleh MI, Rahman S, Townell NH. Open versus laparoscopic cholecystectomy:a comparison of postoperative temperature. J R Coll Surg Edinb. 1995;40(2):116-8.
 
4) Clark JA, Bar-Yosef S, Anderson A, et al. Postoperative hyperthermia following off-pump versus on-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2005;19(4):426-9.
 
5) O'Grady NP, Barie PS, Bartlett JG, et al. Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis. 1998;26(5):1042-59.
 
6) Weed HG, Baddour LM. Postoperative fever. UpToDate. 2017.
 
7) Mavros MN, Velmahos GC, Falagas ME. Atelectasis as a cause of postoperative fever:where is the clinical evidence? Chest. 2011;140(2):418-24.
 
8) Bartlett P, Reingold AL, Graham DR, et al. Toxic shock syndrome associated with surgical wound infections. JAMA. 1982;247(10):1448-50.
 
9) Cobb WS, Paton BL, Novitsky YW, et al. Intra-abdominal placement of antimicrobial-impregnated mesh is associated with noninfectious fever. Am Surg. 2006;72(12):1205-8;discussion 1208-9.
 
10) Dasararaju R, Marques MB. Adverse effects of transfusion. Cancer Control. 2015;22(1):16-25.
 
11) 日本輸血・細胞治療学会 輸血療法委員会 厚生労働科学研究 医薬品・医療機器等レギュラトリーサイエンス総合研究事業. 輸血副作用対応ガイド. 2011.
 
12) Osterman JL, Arora S. Blood product transfusions and reactions. Emerg Med Clin North Am. 2014;32(3):727-38.
 
13) van der Kooi TI, de Boer AS, Mannien J, et al. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med. 2007;33(2):271-8.
 
14) Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903.
 
15) Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208.
 
16) American Thoracic Society;Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
 
17) Zingg W, Pittet D. Peripheral venous catheters:an under-evaluated problem. Int J Antimicrob Agents. 2009;34 Suppl 4:S38-42.
 
18) Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices:a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159-71.
 
19) Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med. 2002;30(12):2632-5.
 
20) Higuchi R, Takada T, Strasberg SM, et al;Tokyo Guideline Revision Committee. TG13 miscellaneous etiology of cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):97-105. doi:10.1007/s00534-012-0565-z.
 
21) Sifri CD, Madoff LC. Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition. Elsevier;2015. p.77, 960-8.e3.
 
22) Liu FL, Li H, Wang XF, et al. Acute acalculous cholecystitis immediately after gastric operation:case report and literatures review. World J Gastroenterol. 2014;20(30):10642-50.
 
23) Kang EH, Lee EY, Lee YJ. Clinical features and risk factors of postsurgical gout. Ann Rheum Dis. 2008;67(9):1271-5.
 
24) Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease. N Engl J Med. 2016;374(26):2575-84.
 
25) Hirose CB, Wright RW. Calcium pyrophosphate dihydrate deposition disease (pseudogout) after total knee arthroplasty. J Arthroplasty. 2007;22(2):273-6.
 
26) White MT, Morgan A, Hopton D. Postoperative pancreatitis. A study of seventy cases. Am J Surg. 1970;120(2):132-7.
 
27) Thompson JS, Bragg LE, Hodgson PE, et al. Postoperative pancreatitis. Surg Gynecol Obstet. 1988;167(5):377-80.
 
28) Cohen SH, Gerding DN, Johnson S, et al;Society for Healthcare Epidemiology of America;Infectious DiseasesSociety of America. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.
 
29) Olson MM, Shanholtzer CJ, Lee JT Jr, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol. 1994;15(6):371-81.
 
30) Hensgens MP, Goorhuis A, Dekkers OM, et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742-8.
 
31) Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250-78;quiz 279-80.
 
32) William Silen, 小関一英, 監訳. 急性腹症の早期診断 第2版. メディカル・サイエンス・インターナショナル;2010.
 
33) Takada T, Ikusaka M, Ohira Y, et al. Diagnostic usefulness of Carnett's test in psychogenic abdominal pain. Intern Med. 2011;50(3):213-7.
 
34) Desmond P, Raman R, Idikula J. Effect of nasogastric tubes on the nose and maxillary sinus. Crit Care Med. 1991;19(4):509-11.
 
35) Raad II, Sabbagh MF, Caranasos GJ. Acute bacterial sialadenitis:a study of 29 cases and review. Rev Infect Dis. 1990;12(4):591-601.
 
36) Firas Al-Niaimi, Neil Cox. Cellulitis and lymphiedema:a vicious cycle. J Lymphoedema. 2009;4(2):38-42.
 
37) Bassi C, Dervenis C, Butturini G, et al;International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula:an international study group (ISGPF) definition. Surgery. 2005;138(1):8-13.
 
38) Romano F, Caprotti R, Conti M, et al. Thrombosis of the splenoportal axis after splenectomy. Langenbecks Arch Surg. 2006 Sep;391(5):483-8.
 
39) Pien F, Ho PW, Fergusson DJ. Fever and infection after cardiac operation. Ann Thorac Surg. 1982;33(4):382-4.
 
40) Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119(5):1461-8.
 
41) Farinas MC, Gald Peralta F, Bernal JM, et al. Suppurative mediastinitis after open-heart surgery:a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis. 1995;20(2):272-9.
 
42) Bor DH, Rose RM, Modlin JF, et al. Mediastinitis after cardiovascular surgery. Rev Infect Dis. 1983;5(5):885-97.
 
43) El Oakley RM, Wright JE. Postoperative mediastinitis:classification and management. Ann Thorac Surg. 1996;61(3):1030-6.
 
44) Fowler VG Jr, Kaye KS, Simel DL, et al. Staphylococcus aureus bacteremia after median sternotomy:clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation. 2003;108(1):73-8. Epub 2003 Jun 23.
 
45) Bucekova E, Simkova I, Hulman M. Postpericardiotomy syndrome - post-cardiac injury syndrome. Bratisl Lek Listy. 2012;113(8):481-5.
 
46) Forgacs P, Geyer CA, Freidberg SR. Characterization of chemical meningitis after neurological surgery. Clin Infect Dis. 2001;32(2):179-85.
 
47) Chatzisotiriou AS, Selviaridis PK, Kontopoulos VA, et al. Delayed persistent hyperthermia after resection of a craniopharyngioma. Pediatr Neurosurg. 2004;40(4):196-202.
 
48) Young MH, Upchurch GR Jr, Malani PN. Vascular graft infections. Infect Dis Clin North Am. 2012;26(1):41-56.
 
49) Voute MT, Bastos Goncalves FM, van de Luijtgaarden KM, et al. Stent graft composition plays a material role in the postimplantation syndrome. J Vasc Surg. 2012;56(6):1503-9.
 
50) Blum U, Voshage G, Lammer J, et al. Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N Engl J Med. 1997;336(1):13-20.
 
51) Schwandt A, Andrews SJ, Fanning J. Prospective analysis of a fever evaluation algorithm after major gynecologic surgery. Am J Obstet Gynecol. 2001;184(6):1066-7.
 
52) Kawamura I, Hirashima Y, Tsukahara M, et al. Microbiology of pelvic lymphocyst infection after lymphadenectomy for malignant gynecologic tumors. Surg Infect (Larchmt). 2015;16(3):244-6.
 
53) Ghosh S, Charity RM, Haidar SG, et al. Pyrexia following total knee replacement. Knee. 2006;13(4):324-7.
 
54) Cunha BA. Fever in the intensive care unit. Intensive Care Med. 1999;25(7):648-51.
 
55) Mackowiak PA, LeMaistre CF. Drug fever:a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature. Ann Intern Med. 1987;106(5):728-33.
 
56) Patel RA, Gallagher JC. Drug fever. Pharmacotherapy. 2010;30(1):57-69.
 
57) Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clin Microbiol Infect. 2000;6(12):633-4.
 
58) Johnson DH. Drug fever. Infect Dis Clin North Am. 1996;10(1):85-91.
 

12 他科との連携が必要な皮膚軟部組織感染症 壊死性軟部組織感染症を見逃がさない

P.357 掲載の参考文献
1) Christensen KL, Holman RC, Steiner CA, et al. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7):1025-35.
 
2) Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections:2014 update by the infec-tious diseases society of America. Clin Infect Dis. 2014;59(2):147-59.
 
3) Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest. 1996;110(1):219-29.
 
4) Pasternack MS, Swartz MN. Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition. Elsevier;2015. p.95. 1194-215.e3.
 
5) Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis. 1986;18(6):519-24.
 
6) Eriksson B, Jorup-Ronstrom C, Karkkonen K, et al. Erysipelas:clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis. 1996;23(5):1091-8.
 
7) Ellis Simonsen SM, van Orman ER, Hatch BE, et al. Cellulitis incidence in a defined population. Epidemiol Infect. 2006;134(2):293-9.
 
8) Raff AB, Kroshinsky D. Cellulitis:A Review. JAMA. 2016;316(3):325-37.
 
9) Pallin DJ, Binder WD, Allen MB, et al. Clinical trial:comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versuscephalexin alone for treatment of uncomplicated cellulitis:a randomized controlled trial. Clin Infect Dis. 2013;56(12):1754-62.
 
10) Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004;350(9):904-12.
 
11) Woo PC, Lum PN, Wong SS, et al. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis. 2000;19(4):294-7.
 
12) Newell PM, Norden CW. Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults. J Clin Microbiol. 1988;26(3):401-4.
 
13) Alsaawi A, Alrajhi K, Alshehri A, et al. Ultrasonography for the diagnosis of patients with clinically suspected skin and soft tissue infections:a systematic review of the literature. Eur J Emerg Med. 2017;24(3):162-9.
 
14) Gunderson CG, Chang JJ. Overuse of compression ultrasound for patients with lower extremity cellulitis. Thromb Res. 2014;134(4):846-50.
 
15) Anaya DA, Dellinger EP. Necrotizing soft-tissue infection:diagnosis and management. Clin Infect Dis. 2007;44(5):705-10.
 
16) William D. Harrison, Birender Kapoor. Necrotizing soft tissue infection:principles of diagnosis and management. Orthop Trauma. 2016;30(3):223-31.
 
17) Wong CH, Wang YS. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis. 2005;18(2):101-6.
 
18) Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score:a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-41.
 
19) Barie PS. The laboratory risk indicator for necrotizing fasciitis (LRINEC) score:useful tool or paralysis by analysis? Crit Care Med. 2004;32(7):1618-9.
 

13 感染症内科医が併診すべき菌血症 黄色ブドウ球菌菌血症とカンジダ血症

P.371 掲載の参考文献
1) Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia:results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451-61.
 
2) Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309-17.
 
3) Palraj BR, Baddour LM, Hess EP, et al. Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT):scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2015;61(1):18-28.
 
4) Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163(17):2066-72.
 
5) Bernard L, Dinh A, Ghout I, et al;Duration of Treatment for Spondylodiscitis (DTS) study group. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis:an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875-82.
 
6) Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J, et al;REIPI/SAB group. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57(9):1225-33.
 
7) Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia:a review. JAMA. 2014;312(13):1330-41.
 
8) Forsblom E, Ruotsalainen E, Ollgren J, et al. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2013;56(4):527-35.
 
9) Takakura S, Fujihara N, Saito T, et al. Improved clinical outcome of patients with Candida bloodstream infections through direct consultation by infectious diseases physicians in a Japanese university hospital. Infect Control Hosp Epidemiol. 2006;27(9):964-8. Epub 2006 Aug 14.
 
10) Antinori S, Milazzo L, Sollima S, et al. Candidemia and invasive candidiasis in adults:A narrative review. Eur J Intern Med. 2016;34:21-8.
 
11) Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients:data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695-703.
 
12) Takakura S, Fujihara N, Saito T, et al. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother. 2004;53(2):283-9.
 
13) Spellberg BJ, Filler SG, Edwards JE Jr. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006;42(2):244-51.
 
14) Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s:a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584-602.
 
15) Mikulska M, Calandra T, Sanguinetti M, et al;Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis:recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14(6):R222.
 
16) Lefort A, Chartier L, Sendid B, et al;French Mycosis Study Group. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18(4):E99-E109.
 
17) Fernandez-Cruz A, Cruz Menarguez M, Munoz P, et al;GAME Study Group (Grupo de Apoyo al Manejo de la Endocarditis). The search for endocarditis in patients with candidemia:a systematic recommendation for echocardiography? A prospective cohort. Eur J Clin Microbiol Infect Dis. 2015;34(8):1543-9.
 
18) Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis:2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50.
 
19) Takesue Y, Ueda T, Mikamo H, et al;ACTIONs Project. Management bundles for candidaemia:the impact of compliance on clinical outcomes. J Antimicrob Chemother. 2015;70(2):587-93.
 
20) Takakura S, Fujihara N, Saito T, et al. Improved clinical outcome of patients with Candida bloodstream infections through direct consultation by infectious diseases physicians in a Japanese university hospital. Infect Control Hosp Epidemiol. 2006;27(9):964-8. Epub 2006 Aug 14.
 
21) Farmakiotis D, Kyvernitakis A, Tarrand JJ, et al. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia:a potential benefit from infectious disease consultation. Clin Microbiol Infect. 2015;21(1):79-86.
 

14 下痢症患者の診断アプローチ たかが下痢, されど下痢

P.406 掲載の参考文献
1) Guerrant RL, Van Gilder T, Steiner TS, et al;Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32(3):331-51.
 
2) LaRocque RC, Calderwood SB. Syndromes of Enteric Infection. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition. Elsevier;2015. p.98, 1238-47.e2.
 
3) 青木眞. レジデントのための感染症診療マニュアル第3版. 医学書院;2015. p.685.
 
4) Wistrom J, Jertborn M, Ekwall E, et al. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med. 1992;117(3):202-8.
 
5) Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996;22(6):1019-25.
 
6) Goodman LJ, Trenholme GM, Kaplan RL, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990;150(3):541-6.
 
7) Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342(26):1930-6.
 
8) 大西健児, 相野田祐介, 今村顕史, 他;一般社団法人日本感染症学会, 公益社団法人日本化学療法学会JAID/JSC感染症治療ガイド・ガイドライン作成委員会腸管感染症ワーキンググループ. JAID/JSC感染症治療ガイドライン2015 腸管感染症. 感染症学雑誌(0387-5911). 2016;90(1):31-65.
 
9) Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med. 2004;350(1):38-47.
 
10) DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92(11):1962-75.
 
11) Barr W, Smith A. Acute diarrhea. Am Fam Physician. 2014;89(3):180-9.
 
12) DuPont HL. Persistent Diarrhea:A Clinical Review. JAMA. 2016;315(24):2712-23.
 
13) Juckett G, Trivedi R. Evaluation of chronic diarrhea. Am Fam Physician. 2011;84(10):1119-26.
 
14) Polage CR, Solnick JV, Cohen SH. Nosocomial diarrhea:evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis. 2012;55(7):982-9.
 
15) Steiner TS, et al. Principles and syndromes of enteric infection. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th edition. Elsevier;2009. p.1343.
 
16) 須河恭敬, 山本博幸, 篠村恭久. 下痢の病態メカニズム. 診断と治療. 2013;101(2):205-10.
 
17) American Medical Association;Centers for Disease Control and Prevention;Center for Food Safety and Applied Nutrition, Food and Drug Administration;Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses:a primer for physicians. MMWR Recomm Rep. 2001;50(RR-2):1-69.
 
18) Cohen SH, Gerding DN, Johnson S, et al;Society for Healthcare Epidemiology of America;Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.
 
19) McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA. 1999;281(11):1022-9.
 
20) Puylaert JB, Vermeijden RJ, van der Werf SD, et al. Incidence and sonographic diagnosis of bacterial ileocaecitis masquerading as appendicitis. Lancet. 1989;2(8654):84-6.
 
21) Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults:a systematic review. JAMA. 2015;313(4):398-408.
 
22) Silletti RP, Lee G, Ailey E. Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens. J Clin Microbiol. 1996;34(5):1161-5.
 
23) Wang H, Murdoch DR. Detection of Campylobacter species in faecal samples by direct Gram stain microscopy. Pathology. 2004;36(4):343-4.
 
24) Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med. 2004;351(23):2417-27.
 
25) 厚生労働省食中毒統計資料. (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/shokuhin/syokuchu/04.html)
 
26) DuPont HL. Clinical practice. Bacterial diarrhea. N Engl J Med. 2009;361(16):1560-9.
 
27) Al-Abri SS, Beeching NJ, Nye FJ. Traveller's diarrhoea. Lancet Infect Dis. 2005;5(6):349-60.
 
28) DuPont HL. Systematic review:prevention of travellers' diarrhoea. Aliment Pharmacol Ther. 2008;27(9):741-51.
 
29) Koo HL, Ajami NJ, Jiang ZD, et al. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010;48(5):1673-6.
 
30) Goodgame R. Emerging Causes of Traveler's Diarrhea:Cryptosporidium, Cyclospora, Isospora, and Microsporidia. Curr Infect Dis Rep. 2003;5(1):66-73.
 
31) Evans MR, Shickle D, Morgan MZ. Travel illness in British package holiday tourists:prospective cohort study. J Infect. 2001;43(2):140-7.
 
32) Cobelens FG, Leentvaar-Kuijpers A, Kleijnen J, et al. Incidence and risk factors of diarrhoea in Dutch travellers:consequences for priorities in pre-travel health advice. Trop Med Int Health. 1998;3(11):896-903.
 
33) Schindler VM, Jaeger VK, Held L, et al. Travel style is a major risk factor for diarrhoea in India:a prospective cohort study. Clin Microbiol Infect. 2015;21(7):676.e1-4.
 
34) Barrett J, Brown M. Travellers' diarrhoea. BMJ. 2016;353:i1937.
 
35) Hill DR, Beeching NJ. Travelers' diarrhea. Curr Opin Infect Dis. 2010;23(5):481-7.
 
36) Pitzurra R, Steffen R, Tschopp A, et al. Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations. BMC Infect Dis. 2010;10:231.
 
37) Aichinger E, Schleck CD, Harmsen WS, et al. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):3795-7.
 
38) Mattila E, Arkkila P, Mattila PS, et al. Extraintestinal Clostridium difficile infections. Clin Infect Dis. 2013;57(6):e148-53.
 
39) Haran JP, Hayward G, Skinner S, et al. Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home:risk of administering IV antibiotics. Am J Emerg Med. 2014;32(10):1195-9.
 
40) Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med. 1986;146(1):95-100.
 
41) Olson MM, Shanholtzer CJ, Lee JT Jr, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol. 1994;15(6):371-81.
 
42) Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539-48.
 
43) Bingley PJ, Harding GM. Clostridium difficile colitis following treatment with metronidazole and vancomycin. Postgrad Med J. 1987;63(745):993-4.
 
44) Pepin J, Valiquette L, Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173(9):1037-42.
 
45) Smith SA, Campbell SJ, Webster D, et al. A study of the prevalence of cytotoxic and non-cytotoxic Klebsiella oxytoca fecal colonization in two patient populations. Can J Infect Dis Med Microbiol. 2009;20(4):e169-72.
 
46) Zollner-Schwetz I, Hogenauer C, Joainig M, et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis. 2008;47(9):e74-8.
 
47) Hogenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355(23):2418-26.
 
48) Bauer TM, Lalvani A, Fehrenbach J, et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA. 2001;285(3):313-9.
 
49) Munch A, Aust D, Bohr J, et al;European Microscopic Colitis Group (EMCG). Microscopic colitis:Current status, present and future challenges:statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012;6(9):932-45.
 

書評

最近チェックした商品履歴

Loading...